Cargando…
243P CDK4/6 inhibitors in clinical practice during COVID-19 pandemic: Comparative analysis of the clinical impact of the pandemic for metastatic breast cancer patients during first and second waves in the UK
Autores principales: | Fouda, M.M., Kuriakose, V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454310/ http://dx.doi.org/10.1016/j.annonc.2021.08.526 |
Ejemplares similares
-
Assessing the Impact of the COVID-19 outbreak on the oncological practice regarding metastatic breast cancer patients treated with CDK4/6 inhibitors
por: Fouda, M., et al.
Publicado: (2021) -
The experience of UK patients with bladder cancer during the second wave of the COVID‐19 pandemic
por: Russell, Beth, et al.
Publicado: (2022) -
Tailored breast imaging during the first wave and preparedness for the second wave of COVID-19 pandemic
por: Shimpi, Trishna, et al.
Publicado: (2020) -
Cameroon's bold response to the COVID-19 pandemic during the first and second waves
por: Esso, Linda, et al.
Publicado: (2021) -
Performance analysis of English hospitals during the first and second waves of the coronavirus pandemic
por: Kuosmanen, Timo, et al.
Publicado: (2023)